# Zoliflodacin in Uncomplicated Gonorrhoea

> **NCT03959527** · PHASE3 · COMPLETED · sponsor: **Global Antibiotics Research and Development Partnership** · enrollment: 1011 (actual)

## Conditions studied

- Gonorrhea

## Interventions

- **DRUG:** zoliflodacin
- **DRUG:** ceftriaxone
- **DRUG:** azithromycin

## Key facts

- **NCT ID:** NCT03959527
- **Lead sponsor:** Global Antibiotics Research and Development Partnership
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-06
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-09-18
- **Target enrollment:** 1011 (ACTUAL)
- **Last updated:** 2025-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03959527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03959527, "Zoliflodacin in Uncomplicated Gonorrhoea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03959527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*